{"entity":{"type":"insider","cik":"0001673528","url":"/insider/0001673528","json_url":"/insider/0001673528.json","name":"Faga Daniel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":15,"first":"2017-05-17","last":"2026-03-27","span_basis":"filed_date"},"name_variants":[{"name":"Faga Daniel","source":"filing","n_filings":15,"first_seen":"2017-05-17","last_seen":"2026-03-27"}],"transactions":[{"id":5934543,"accession":"0001673528-26-000007","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001673528-26-000007","line_url":"/filing/0001673528-26-000007","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17679.0,"shares_display":"17,679","price_per_share":61.60974841902823,"price_display":"61.61","price_state":"stated","total_value":1089198.7423,"total_display":"1,089,198.74","total_whole":"1,089,199","shares_owned_after":506902.0,"shares_owned_after_display":"506,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-27","filed_date":"2026-03-27","scope":"insider","n_lines":10},{"id":6098007,"accession":"0001673528-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001673528-26-000006","line_url":"/filing/0001673528-26-000006#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14281.0,"shares_display":"14,281","price_per_share":44.71,"price_display":"44.71","price_state":"stated","total_value":638503.51,"total_display":"638,503.51","total_whole":"638,504","shares_owned_after":479344.0,"shares_owned_after_display":"479,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-09","scope":"insider"},{"id":6174661,"accession":"0001673528-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001673528-26-000004","line_url":"/filing/0001673528-26-000004#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9202.0,"shares_display":"9,202","price_per_share":45.11,"price_display":"45.11","price_state":"stated","total_value":415102.22,"total_display":"415,102.22","total_whole":"415,102","shares_owned_after":466787.0,"shares_owned_after_display":"466,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-08","scope":"insider"},{"id":5757945,"accession":"0001673528-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001673528-26-000002","line_url":"/filing/0001673528-26-000002#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15309.0,"shares_display":"15,309","price_per_share":43.26,"price_display":"43.26","price_state":"stated","total_value":662267.34,"total_display":"662,267.34","total_whole":"662,267","shares_owned_after":458139.0,"shares_owned_after_display":"458,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider"},{"id":2928818,"accession":"0001415889-24-009164","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009164","line_url":"/filing/0001415889-24-009164#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":21.4225,"price_display":"21.42","price_state":"stated","total_value":64267.5,"total_display":"64,267.50","total_whole":"64,268","shares_owned_after":749087.0,"shares_owned_after_display":"749,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-03-26","scope":"insider"},{"id":2928812,"accession":"0001415889-24-009164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009164","line_url":"/filing/0001415889-24-009164#line-1","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":145940.0,"shares_display":"145,940","price_per_share":22.7846,"price_display":"22.78","price_state":"stated","total_value":3325184.524,"total_display":"3,325,184.52","total_whole":"3,325,185","shares_owned_after":752087.0,"shares_owned_after_display":"752,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-22","filed_date":"2024-03-26","scope":"insider"},{"id":2248001,"accession":"0001209191-24-001277","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001277","line_url":"/filing/0001209191-24-001277#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6866.0,"shares_display":"6,866","price_per_share":21.81,"price_display":"21.81","price_state":"stated","total_value":149747.46,"total_display":"149,747.46","total_whole":"149,747","shares_owned_after":898027.0,"shares_owned_after_display":"898,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":5508046,"accession":"0001214659-21-001205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-001205","line_url":"/filing/0001214659-21-001205#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Officer (EVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1340.0,"shares_display":"1,340","price_per_share":194.38,"price_display":"194.38","price_state":"stated","total_value":260469.2,"total_display":"260,469.20","total_whole":"260,469","shares_owned_after":30638.0,"shares_owned_after_display":"30,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider"},{"id":5407558,"accession":"0001214659-21-000333","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-000333","line_url":"/filing/0001214659-21-000333","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Officer (EVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2625.0,"shares_display":"2,625","price_per_share":216.32532342857144,"price_display":"216.33","price_state":"stated","total_value":567853.974,"total_display":"567,853.97","total_whole":"567,854","shares_owned_after":23615.0,"shares_owned_after_display":"23,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-08","scope":"insider","n_lines":2},{"id":5081994,"accession":"0001609351-17-000109","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001609351-17-000109","line_url":"/filing/0001609351-17-000109#line-4","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":127500.0,"total_display":"127,500.00","total_whole":"127,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-24","filed_date":"2017-10-24","scope":"insider"},{"id":5081986,"accession":"0001609351-17-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-17-000109","line_url":"/filing/0001609351-17-000109#line-2","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":79.95,"price_display":"79.95","price_state":"stated","total_value":479700.0,"total_display":"479,700.00","total_whole":"479,700","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-20","filed_date":"2017-10-24","scope":"insider"},{"id":4263915,"accession":"0001609351-17-000106","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-17-000106","line_url":"/filing/0001609351-17-000106#line-2","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":127500.0,"total_display":"127,500.00","total_whole":"127,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-19","filed_date":"2017-09-20","scope":"insider"},{"id":4980434,"accession":"0001609351-17-000104","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001609351-17-000104","line_url":"/filing/0001609351-17-000104","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":82.5015,"price_display":"82.50","price_state":"stated","total_value":495009.0,"total_display":"495,009.00","total_whole":"495,009","shares_owned_after":900.0,"shares_owned_after_display":"900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-12","filed_date":"2017-09-14","scope":"insider","n_lines":2},{"id":4134181,"accession":"0001609351-17-000102","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001609351-17-000102","line_url":"/filing/0001609351-17-000102","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":85.015,"price_display":"85.02","price_state":"stated","total_value":255045.0,"total_display":"255,045.00","total_whole":"255,045","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-07","filed_date":"2017-09-11","scope":"insider","n_lines":2},{"id":4245017,"accession":"0001609351-17-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-17-000081","line_url":"/filing/0001609351-17-000081#line-2","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":210000.0,"total_display":"210,000.00","total_whole":"210,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-24","filed_date":"2017-07-26","scope":"insider"},{"id":4319483,"accession":"0001609351-17-000066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-17-000066","line_url":"/filing/0001609351-17-000066#line-2","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":62.71,"price_display":"62.71","price_state":"stated","total_value":282195.0,"total_display":"282,195.00","total_whole":"282,195","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-29","filed_date":"2017-06-29","scope":"insider"},{"id":4756941,"accession":"0001609351-17-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-17-000037","line_url":"/filing/0001609351-17-000037#line-2","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001673528","owner_name":"Faga Daniel","owner_display_name":"Faga Daniel","owner_url":"/insider/0001673528","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":56.9,"price_display":"56.90","price_state":"stated","total_value":256050.0,"total_display":"256,050.00","total_whole":"256,050","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001370053","name":"ANAPTYSBIO, INC","url":"/issuer/0001370053","role":"Director, Officer (President, CEO)","n_filings":6,"first_seen":"2024-01-09","last_seen":"2026-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Officer (EVP, Chief Operating Officer)","n_filings":2,"first_seen":"2021-01-08","last_seen":"2021-02-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001609351","name":"Spark Therapeutics, Inc.","url":"/issuer/0001609351","role":"Officer (Chief Business Officer)","n_filings":7,"first_seen":"2017-05-17","last_seen":"2017-10-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001673528","retrieved_at":"2026-08-23T07:16:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}